Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19.
作者信息
Jolobe Oscar M P
机构信息
Flat 6 Souchay Court, 1 Clothorn Road, Manchester M20 6BR, United Kingdom.
出版信息
Am J Emerg Med. 2022 Apr;54:318-319. doi: 10.1016/j.ajem.2021.05.053. Epub 2021 May 23.
Abstract
摘要
相似文献
1
Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19.扩大由新冠病毒腺病毒载体疫苗引起的血栓性血小板减少综合征的临床谱。
Am J Emerg Med. 2022 Apr;54:318-319. doi: 10.1016/j.ajem.2021.05.053. Epub 2021 May 23.
2
Covid-19 vaccination in patients with immune-mediated thrombotic thrombocytopenic purpura: a single-referral center experience.免疫性血小板减少性紫癜患者的新冠病毒疫苗接种：单转诊中心经验
Haematologica. 2023 Jul 1;108(7):1957-1959. doi: 10.3324/haematol.2022.282311.
3
Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.COVID-19 疫苗接种和/或同时 COVID-19 感染可能引发免疫性血栓性血小板减少性紫癜（iTTP）复发。
BMJ Case Rep. 2022 Jul 28;15(7):e247524. doi: 10.1136/bcr-2021-247524.
4
Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination.接种 Ad26.COV2-S 后发生血栓性血小板减少性紫癜。
Am J Emerg Med. 2021 Nov;49:441.e3-441.e4. doi: 10.1016/j.ajem.2021.05.001. Epub 2021 May 4.
5
No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey.基于mRNA的COVID-19疫苗不会加重先天性血栓性血小板减少性紫癜：一项日本登记调查。
Ann Hematol. 2022 May;101(5):1115-1117. doi: 10.1007/s00277-022-04774-2. Epub 2022 Feb 4.
6
Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine?获得性血栓性血小板减少性紫癜：新冠mRNA疫苗接种后的罕见巧合？
Semin Thromb Hemost. 2023 Feb;49(1):89-91. doi: 10.1055/s-0042-1744301. Epub 2022 Jun 27.
7
Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination.新型冠状病毒肺炎疫苗接种后免疫介导的血栓性血小板减少性紫癜
Blood. 2022 Apr 21;139(16):2565-2569. doi: 10.1182/blood.2021015149.
8
Comment on: COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents.关于《新冠病毒疫苗（mRNA BNT162b2）与青少年新冠病毒感染诱发的血栓性血小板减少性紫癜》的评论
Pediatr Blood Cancer. 2022 Dec;69(12):e29749. doi: 10.1002/pbc.29749. Epub 2022 Apr 29.
9
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.血栓性血小板减少性紫癜：COVID-19 bnt162b2 疫苗接种后的新威胁
Int J Hematol. 2021 Nov;114(5):626-629. doi: 10.1007/s12185-021-03190-y. Epub 2021 Jul 15.
10
Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine.接种辉瑞-生物科技公司新冠疫苗后发生的免疫介导性血栓性血小板减少性紫癜
Haematologica. 2022 Apr 1;107(4):1008-1010. doi: 10.3324/haematol.2021.279535.
本文引用的文献
1
Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia.接种 ChAdOx1 nCov-19 疫苗后脑梗死：疫苗诱导的免疫性血栓性血小板减少症的灾难性变异型。
Nat Commun. 2021 Aug 2;12(1):4663. doi: 10.1038/s41467-021-25010-x.
2
Prothrombotic immune thrombocytopenia after COVID-19 vaccination.接种 COVID-19 疫苗后的促血栓形成免疫性血小板减少症。
Blood. 2021 Jul 29;138(4):350-353. doi: 10.1182/blood.2021011958.
3
Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT).疫苗诱导的免疫性血小板减少症和血栓形成（VITT）
Res Pract Thromb Haemost. 2021 Jun 1;5(5):e12529. doi: 10.1002/rth2.12529. eCollection 2021 Jun.
4
Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination.接种 Ad26.COV2-S 后发生血栓性血小板减少性紫癜。
Am J Emerg Med. 2021 Nov;49:441.e3-441.e4. doi: 10.1016/j.ajem.2021.05.001. Epub 2021 May 4.
5
COVID-19 vaccine induced prothrombotic immune thrombocytopenia.新冠病毒疫苗诱导的血栓性免疫性血小板减少症
Eur Heart J. 2021 Aug 31;42(33):3206. doi: 10.1093/eurheartj/ehab237.
6
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.美国 2021 年 3 月 2 日至 4 月 21 日 Ad26.COV2.S 疫苗接种后出现脑静脉窦血栓形成伴血小板减少的病例报告。
JAMA. 2021 Jun 22;325(24):2448-2456. doi: 10.1001/jama.2021.7517.
7
Fatal cerebral haemorrhage after COVID-19 vaccine.接种新冠病毒疫苗后发生致命性脑溢血。
Tidsskr Nor Laegeforen. 2021 Apr 29;141. doi: 10.4045/tidsskr.21.0312. Print 2021 Apr 30.
8
Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure.接种阿斯利康“新冠疫苗”后出现血小板减少症和颅内静脉窦血栓形成
J Clin Med. 2021 Apr 9;10(8):1599. doi: 10.3390/jcm10081599.
9
Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination.新冠病毒疫苗接种后发生的脑静脉血栓形成和血小板减少症
Thromb Res. 2021 Jun;202:182-183. doi: 10.1016/j.thromres.2021.04.001. Epub 2021 Apr 8.
10
Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine.患者在接种新型冠状病毒病腺病毒载体疫苗后新发血小板减少伴急性缺血性脑卒中及出血。
J Thromb Haemost. 2021 Jul;19(7):1771-1775. doi: 10.1111/jth.15347. Epub 2021 May 5.
Zotero 插件